Senior insider sale
Chief Legal & Compliance at ZEVRA THERAPEUTICS, INC. — senior position signals high conviction
$915.3K
77.22K shares
What this filing means
THOMPSON RAHSAAN plans to sell 77.22K shares of ZEVRA THERAPEUTICS, INC. valued at approximately $915.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/14/2026ACC: 0001950047-26-008134
OfficerOther· Chief Legal & Compliance
Since Jan 2026
77.22K
Shares to sell
$915.3K
Approx. market value
42.67K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
6/21/2025
42.67KTotal acquired42.67K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/21/2025 | Restricted Stock Units N/A | 42.67K | — |
| Total | 42.67K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
34.56K
Market value
$438.3K
6/22/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
42.67K
Market value
$477.0K
8/14/2026
Total
Units
77.22K
Value
$915.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/22/2026 | 34.56K | $438.3K | — | Completed |
| Planned — Approximate Date | ||||
8/14/2026 | 42.67K | $477.0K | NASDAQ | Planned |
| Total | 77.22K | $915.3K | ||